Lataa...
Antibody-Drug Conjugates: Possibilities and Challenges
The design of Antibody Drug Conjugates (ADCs) as efficient targeting agents for tumor cell is still in its infancy for clinical applications. This approach incorporates the antibody specificity and cell killing activity of chemically conjugated cytotoxic agents. Antibody in ADC structure acts as a t...
Tallennettuna:
| Julkaisussa: | Avicenna J Med Biotechnol |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Avicenna Research Institute
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6359697/ https://ncbi.nlm.nih.gov/pubmed/30800238 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|